Association of serum uric acid with proteinuria in type 2 diabetic patients

Journal of Research in Medical Sciences

Volumn 18, Issue 1, 2013, Pages 44-46

  Behradmanesh, Saeed ^a   Horestani, Mohammad Karami ^a   Baradaran, Azar ^a   Nasri, Hamid ^b  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Proteinuria; Renal failure; Type 2 diabetes mellitus; Uric acid

Indexed keywords

CREATININE; HEMOGLOBIN A1C;

ADULT; AGED; ANALYTICAL RESEARCH; ARTICLE; BLOOD SAMPLING; BODY MASS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; URIC ACID BLOOD LEVEL;

EID: 84881176095     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Tolouian R, Hernandez GT. Prediction of diabetic nephropathy: The need for a sweet biomarker. J Nephropathology 2013;2:4-5.
2. Rahimi Z. ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. J Nephropathology 2012;1:143-51.
3. Rouhi H, Ganji F. Effect of N-acetyl cysteine on serum lipoprotein (a) and proteinuria in type 2 diabetic patients. J Nephropathology 2013;1:61-6.
4. Jalal DI, Rivard CJ, Johnson RJ, Maahs DM, McFann K, Rewers M, et al. Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: Findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant 2010;25:1865-9.
5. Baradaran A. Lipoprotein (a), type 2 diabetes and nephropathy; the mystery continues. J Nephropathology 2012;1:126-9.
6. Tavafi M. Diabetic nephropathy and antioxidants. J Nephropathology 2013;2:20-7.
7. Hovind P, Rossing P, Tarnow L, Johnson RJ, Parving HH. Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: An inception cohort study. Diabetes 2009;58:1668-71.
8. Gheissari A, Hemmatzadeh S, Merrikhi A, Fadaei Tehrani S, Madihi Y. Chronic kidney disease in children: A report from a tertiary care center over 11 years. J Nephropathology 2012;1:177-82.
9. Unsal A, Koc Y, Basturk T, Akgun AO, Sakaci T, Ahbap E. Risk factors for progression of renal disease in patient with diabetic nephropathy. Eur Rev Med Pharmacol Sci 2012;16:878-83.
10. Nasri H. Hypertension and renal failure with right arm pulse weakness in a 65 years old man. J Nephropathology. 2012;1:130-3.
11. Coll-de-Tuero G, Mata-Cases M, Rodriguez-Poncelas A, Pepió JM, Roura P, Benito B, et al. Chronic kidney disease in the type 2 diabetic patients: Prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area. BMC Nephrol 2012;13:87.
12. Kari J. Epidemiology of chronic kidney disease in children. J Nephropathology 2012;1:162-3.
13. Lim AK, Tesch GH. Inflammation in diabetic nephropathy. Mediators Inflamm 2012. doi: 10.1155/2012/146154.
14. Gheissari A, Mehrasa P, Merrikhi A, Madihi Y. Acute kidney injury: A pediatric experience over 10 years at a tertiary care center. J Nephropathology 2012;1:101-8.
15. Baradaran A, Behradmanesh S, Nasri H. Association of body mass index and serum vitamin D level in healthy Iranian adolescents. Endokrynol Pol 2012;63:29-33.
16. Nasri H. Association of serum lipoprotein (a) with hypertension in diabetic patients. Saudi J Kidney Dis Transpl 2008;19:420-7.
17. Nasri H, Yazdani M. The relationship between serum LDL-cholesterol, HDL-cholesterol and systolic blood pressure in patients with type 2 diabetes. Kardiol Pol 2006;64:1364-8.
18. Solati M, Mahboobi HR. Paraoxonase enzyme activity anddyslipidemia in chronic renal failure patients. J Nephropathology 2012;1:123-5.
19. Sánchez Niño MD, Ortiz A. Is it or is it not a pathogenic mutation? Is it or is it not the podocyte? J Nephropathology 2012;1:152-4.
20. Bonakdaran S, Ebrahimzadeh S, Noghabi SH. Cardiovascular disease and risk factors in patients with type 2 diabetes mellitus in Mashhad, Islamic Republic of Iran. East Mediterr Health J 2011;17:640-6.
21. Sahni N, Gupta KL. Dietary antioxidents and oxidative stress in predialysis chronic kidney patients. J Nephropathology 2012;1:134-42.
22. Tayebi KH. Short history about renal transplantation program in Iran and the world: Special focus on world kidney day 2012. J Nephropathology 2012;1:5-10.
23. Khajehdehi P. Turmeric: Reemerging of a neglected Asian traditional remedy. J Nephropathology 2012;1:17-22.
24. Bruno RM, Penno G, Daniele G, Pucci L, Lucchesi D, Stea F, et al. Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. Diabetologia 2012;55:1847-55.
25. Doria A, Krolewski AS. Diabetes: Lowering serum uric acid levels to prevent kidney failure. Nat Rev Nephrol 2011;7:495-6.
26. Hovind P, Rossing P, Johnson RJ, Parving HH. Serum uric acid as a new player in the development of diabetic nephropathy. J Ren Nutr 2011;21:124-7.
27. Sanchez-Lozada LG, Soto V, Tapia E, Avilia-Casado C, Sautin YY, Nakagawa T, et al. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol 2008;295:F1134-41.
28. Kuo CF, Luo SF, See LC, Ko YS, Chen YM, Hwang JS, et al. Hyperuricaemia and accelerated reduction in renal function. Scand J Rheumatol 2011;40:116-21.
29. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67:1739-42.
30. Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, Asano M, et al. Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism 2008;57:625-9.
31. Fu CC, Wu DA, Wang JH, Yang WC, Tseng CH. Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients. Acta Diabetol 2009;46:127-34.
32. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002;13:2888-97.
33. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002;282:F991-7.
34. Assadi F. The epidemic of pediatric chronic kidney disease: The danger of skepticism. J Nephropathology 2012;1:61-4.
35. Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R. Elevated uric acid increasesthe risk for kidney disease. J Am Soc Nephrol 2008;19:2407-13.